Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis

Diabetologia

Volumn 53, Issue 5, 2010, Pages 840-849

  Adler, A I ^a   Erqou, S ^a   Lima, T A S ^a   Robinson, A H N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Amputation; Diabetes; Disease modelling; Epidemiology; HbA1c; Health economics; Hyperglycaemia; Meta analysis; Risk factor; Systematic review

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEG AMPUTATION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

AMPUTATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RISK;

EID: 77952099171     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1638-7     Document Type: Article

References (56)

1. E Selvin S Marinopoulos G Berkenblit, et al. 2004 Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 421 431 1:CAS:528:DC%2BD2cXos1Cjtrk%3D 15381515 (Pubitemid 39281878)
2. IM Stratton AI Adler HA Neil, et al. 2000 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405 412 10.1136/bmj.321.7258.405 1:STN:280:DC%2BD3cvisFWnsg%3D%3D 10938048 (Pubitemid 30609442)
3. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
4. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
5. M Shichiri H Kishikawa Y Ohkubo N Wake 2000 Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 Suppl 2 B21 B29 10860187 (Pubitemid 30185774)
6. HC Gerstein ME Miller RP Byington, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 10.1056/NEJMoa0802743 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D 18539917 (Pubitemid 351831356)
7. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D 18539916 (Pubitemid 351214289)
8. The Diabetes Control and Complications Trial Research Group 1995 Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial Am J Cardiol 75 894 903 10.1016/S0002-9149(99)80683-3
9. RR Holman SK Paul MA Bethel DR Matthews HA Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1 13 10.1056/NEJMp0804448 (Pubitemid 351931090)
10. SA Watts B Daly M Anthony P McDonald A Khoury W Dahar 2001 The effect of age, gender, risk level and glycosylated hemoglobin in predicting foot amputation in HMO patients with diabetes J Am Acad Nurse Pract 13 230 235 1:STN:280:DC%2BD387pslylsg%3D%3D 11930474
11. AJ Boulton 1996 The pathogenesis of diabetic foot problems: an overview Diabet Med 13 Suppl 1 S12 S16 8741822
12. AI Adler EJ Boyko JH Ahroni DG Smith 1999 Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers Diabetes Care 22 1029 1035 10.2337/diacare.22.7.1029 1:STN:280:DyaK1MzhslWqsQ%3D%3D 10388962 (Pubitemid 29293950)
13. RS Most P Sinnock 1983 The epidemiology of lower extremity amputations in diabetic individuals Diabetes Care 6 87 91 10.2337/diacare.6.1.87 1:STN:280:DyaL3s7otF2ktA%3D%3D 6839926 (Pubitemid 13144888)
14. AD Morris R McAlpine D Steinke, et al. 1998 Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit Diabetes Care 21 738 743 10.2337/diacare.21.5.738 1:STN:280:DyaK1c3ltFWhtw%3D%3D 9589233 (Pubitemid 28487064)
15. CJ Schofield G Libby GM Brennan, et al. 2006 Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes Diabetes Care 29 2252 2256 10.2337/dc06-0926 17003302 (Pubitemid 44899861)
16. UK Prospective Diabetes Study (UKPDS) Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854 865 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
17. JA Dormandy B Charbonnel DJ Eckland, et al. 2005 Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 1279 1289 10.1016/S0140-6736(05)67528-9 1:CAS:528:DC%2BD2MXhtVOlu7fO 16214598 (Pubitemid 41416583)
18. PD Home SJ Pocock H Beck-Nielsen, et al. 2007 Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis N Engl J Med 357 28 38 10.1056/NEJMoa073394 1:CAS:528:DC%2BD2sXnsVCqs7w%3D 17551159 (Pubitemid 47026732)
19. SE Moss R Klein BE Klein 1996 Long-term incidence of lower-extremity amputations in a diabetic population Arch Fam Med 5 391 398 10.1001/archfami.5. 7.391 1:STN:280:DyaK283otVKgsA%3D%3D 8664997 (Pubitemid 126445125)
20. JC Olson JR Erbey KY Forrest K Williams DJ Becker TJ Orchard 2002 Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes Metabolism 51 248 254 10.1053/meta.2002.30021 1:CAS:528:DC%2BD38Xht1Wgtbg%3D 11833057 (Pubitemid 34168241)
21. MS Roy B Peng 2008 Six-year incidence of lower extremity arterial disease and associated risk factors in type 1 diabetic African-Americans Diabet Med 25 550 556 10.1111/j.1464-5491.2008.02434.x 1:STN:280:DC%2BD1c3ot1Wksg%3D%3D 18346155 (Pubitemid 351590894)
22. DV Coppini PJ Young C Weng AF Macleod PH Sonksen 1998 Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study Diabet Med 15 765 771 10.1002/(SICI)1096- 9136(199809)15:9<765::AID-DIA663>3.0.CO;2-1 1:STN:280:DyaK1cvgslyhtg%3D%3D 9737806 (Pubitemid 28396529)
23. G Lepore ML Maglio C Cuni, et al. 2006 Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration Diabetes Care 29 1985 10.2337/dc06-0912 16873822 (Pubitemid 44156671)
24. N Chaturvedi CA Abbott A Whalley P Widdows SY Leggetter AJ Boulton 2002 Risk of diabetes-related amputation in South Asians vs Europeans in the UK Diabet Med 19 99 104 10.1046/j.1464-5491.2002.00583.x 1:STN:280: DC%2BD387jvVGksA%3D%3D 11874424 (Pubitemid 34225222)
25. AL Carrington JE Shaw CH van Schie CA Abbott L Vileikyte AJ Boulton 2002 Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25 2010 2015 10.2337/diacare.25.11. 2010 12401748 (Pubitemid 41071060)
26. LM Farnkvist BM Lundman 2003 Outcomes of diabetes care: a population-based study Int J Qual Health Care 15 301 307 10.1093/intqhc/mzg047 12930045 (Pubitemid 36987268)
27. Wells GA, Shea B, O'Connell B et al (2009) The Newcastle-Ottawa quality assessment scale. Ottawa Health Research Institute, Ottawa. Available from www.ohri.ca/programs/clinical-epidemiology/oxford.htm (accessed 2 December 2009)
28. J Danesh R Collins P Appleby R Peto 1998 Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1477 1482 10.1001/jama.279.18.1477 1:STN:280:DyaK1c3mtFWisw%3D%3D 9600484 (Pubitemid 28228207)
29. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 10.1016/0197-2456(86)90046-2 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
30. JP Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analyses BMJ 327 557 560 10.1136/bmj.327.7414.557 12958120
31. M Egger SG Davey M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280:DyaK2svls1KjtA%3D%3D 9310563 (Pubitemid 27387172)
32. CL Tseng U Sambamoorthi D Helmer, et al. 2007 The association between mental health functioning and nontraumatic lower extremity amputations in veterans with diabetes Gen Hosp Psychiatry 29 537 546 10.1016/j.genhosppsych. 2007.08.001 18022047 (Pubitemid 350088160)
33. SE Moss R Klein BE Klein 1999 The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes Care 22 951 959 10.2337/diacare.22.6.951 1:STN:280:DyaK1MzgtVygtA%3D%3D 10372248 (Pubitemid 29241051)
34. HE Resnick EA Carter JM Sosenko, et al. 2004 Incidence of lower-extremity amputation in American Indians: the Strong Heart Study Diabetes Care 27 1885 1891 10.2337/diacare.27.8.1885 15277412 (Pubitemid 38989227)
35. I Muhlhauser H Overmann R Bender V Jorgens M Berger 2000 Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy Diabet Med 17 727 734 10.1046/j.1464-5491.2000.00372.x 1:STN:280:DC%2BD3M7lvFClsw%3D%3D 11110506
36. S Lehto T Ronnemaa K Pyorala M Laakso 1996 Risk factors predicting lower extremity amputations in patients with NIDDM Diabetes Care 19 607 612 10.2337/diacare.19.6.607 1:STN:280:DyaK28zkvVyitw%3D%3D 8725860 (Pubitemid 26181109)
37. AS Jbour NS Jarrah AM Radaideh, et al. 2003 Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan Saudi Med J 24 761 764 12883610
38. WA Davis PE Norman DG Bruce TM Davis 2006 Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study Diabetologia 49 2634 2641 10.1007/s00125-006-0431-0 1:STN:280:DC%2BD28njtFSitg%3D%3D 17001469
39. C Stettler S Allemann P Juni, et al. 2006 Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials Am Heart J 152 27 38 10.1016/j.ahj.2005.09.015 1:CAS:528:DC%2BD28Xms1Gkt7k%3D 16824829 (Pubitemid 43974725)
40. S Genuth DM Nathan S Engel, et al. 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2643 2653 10.1056/NEJMoa052187 1:CAS:528:DC%2BD2MXhtlarsrrJ 16371630 (Pubitemid 41817713)
41. W Duckworth C Abraira T Moritz, et al. 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139 10.1056/NEJMoa0808431 1:CAS:528:DC%2BD1MXnsFWkug%3D%3D 19092145
42. K Rajamani PG Collman JD Best, et al. 2009 Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of randomised controlled trials Lancet 373 1780 1788 10.1016/S0140-6736(09)60698-X 1:CAS:528:DC%2BD1MXmtlektr8%3D 19465233
43. Hunt D (2009) Diabetes: foot ulcers and amputations. Clin Evid (pii: 0602)
44. CD Schraer AI Adler AM Mayer KR Halderson BA Trimble 1997 Diabetes complications and mortality among Alaska Natives: 8 years of observation Diabetes Care 20 314 321 10.2337/diacare.20.3.314 1:STN:280:DyaK2s3gtlyjug%3D%3D 9051380
45. AJ Hennis HS Fraser R Jonnalagadda J Fuller N Chaturvedi 2004 Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention Diabetes Care 27 2636 2641 10.2337/diacare.27.11.2636 15504998 (Pubitemid 39441463)
46. The Global Lower Extremity Amputation Study Group 2000 Epidemiology of lower extremity amputation in centres in Europe. North America and East Asia Br J Surg 87 328 337 10.1046/j.1365-2168.2000.01344.x (Pubitemid 30156360)
47. S Krishnan F Nash N Baker D Fowler G Rayman 2008 Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit Diabetes Care 31 99 101 10.2337/dc07-1178 17934144
48. M Brownlee 2005 The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 1615 1625 10.2337/diabetes.54.6.1615 1:CAS:528: DC%2BD2MXltVaisbk%3D 15919781 (Pubitemid 40770750)
49. AJ Boulton 2008 The diabetic foot: grand overview, epidemiology and pathogenesis Diabetes Metab Res Rev 24 Suppl 1 S3 S6 10.1002/dmrr.833 18442166 (Pubitemid 351802764)
50. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2000 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy N Engl J Med 342 381 389 10.1056/NEJM200002103420603 (Pubitemid 30084536)
51. GE Reiber RE Pecoraro TD Koepsell 1992 Risk factors for amputation in patients with diabetes mellitus. A case-control study Ann Intern Med 117 97 105 1:STN:280:DyaK383ps1CnsA%3D%3D 1605439
52. J Apelqvist CD Agardh 1992 The association between clinical risk factors and outcome of diabetic foot ulcers Diabetes Res Clin Pract 18 43 53 10.1016/0168-8227(92)90054-U 1:STN:280:DyaK3s%2Fns1Kgtw%3D%3D 1446576
53. MA Gamba SL Gotlieb DP Bergamaschi LA Vianna 2004 Lower extremity amputations in diabetic patients: a case-control study Rev Saude Publica 38 399 404 10.1590/S0034-89102004000300010 15243670 (Article in Portuguese)
54. CR Weinberg 1993 Toward a clearer definition of confounding Am J Epidemiol 137 1 8 1:STN:280:DyaK3s7mslahsQ%3D%3D 8434568
55. P Clarke A Gray R Holman 2002 Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) Med Decis Making 22 340 349 12150599 (Pubitemid 34791321)
56. RE Pecoraro GE Reiber EM Burgess 1990 Pathways to diabetic limb amputation. Basis for prevention Diabetes Care 13 513 521 10.2337/diacare.13.5. 513 1:STN:280:DyaK3c3ns1Wmtg%3D%3D 2351029